GlassScriptPhysician profile
Jillian Wynn
NPI 1720764798
$4,329.30
in general payments reported to CMS, 2019-2025
22 companies · $2,559 in 2025
The $2,559 reported for 2025 was more than what 94% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,771 · 2025: $2,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,167 · Travel and Lodging: $1,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,167.22 |
| Travel and Lodging | $1,162.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,156.15 | 2024 | Axonics |
| Intuitive Surgical, INC. | $590.61 | 2025 | |
| Medtronic, INC. | $540.10 | 2025 | Interstim, Infinity Occipitocervical Upper Thoracic System |
| Teleflex LLC | $521.19 | 2024-2025 | Barrigel, Urolift |
| Procept Biorobotics Corporation | $247.16 | 2024-2025 | Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $200.40 | 2024-2025 | |
| Abbvie INC. | $135.94 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $131.20 | 2024-2025 | Provenge |
| Novartis Pharmaceuticals Corporation | $130.74 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $123.19 | 2024-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $115.03 | 2025 | Erleada |
| Endo USA, INC. | $106.92 | 2024-2025 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $69.84 | 2025 | Keytruda |
| Boston Scientific Corporation | $63.36 | 2025 | Axonics |
| Tolmar, INC. | $54.37 | 2025 | Eligard |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $31.93 | 2024 | Illuccix |
| Azurity Pharmaceuticals, INC. | $23.19 | 2025 | Azmiro |
| Bioprotect Medical, INC. | $22.91 | 2025 | Bioprotect Balloon Implant System |
| Progenics Pharmaceuticals, INC. | $20.26 | 2024 | |
| Photocure INC | $15.93 | 2024 | Cysview |
| Myriad Genetic Laboratories, INC. | $15.37 | 2024 | Prolaris |
| Coloplast Corp | $13.51 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Wynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.